John B. Kowalski, Ph.D. Signs a Multi-Year Exclusive Agreement with Sterigenics as a Senior Staff Consultant


Itasca, IL - October 7, 2009: Sterigenics International, a global leader in sterilization services for the medical device and pharmaceutical industries, announced today the signing of a multi-year exclusive agreement with John B. Kowalski, Ph.D., to serve as a Senior Staff Consultant with the SteriPro Consulting team.

John is a broadly trained microbiologist and has 30 years experience in the development, validation, and transfer of sterilization processes for medical products, mainly with the Sterilization Science & Technology group of Johnson & Johnson, where he became Chief Scientist and Executive Director. John most recently has been the proprietor of microGAMMA, LLC, a successful consulting firm specializing in sterilization microbiology, sterilization process development and validation, and quality assurance/regulatory issues.

He has expertise in both radiation and ethylene oxide sterilization, as well as a number of other sterilization processes, such as moist heat, gas plasma and ultraviolet light. In the radiation field, he developed the VDmax methodology for substantiation of a radiation sterilization dose, as well as publishing and co-authoring a number of technical papers on sterilization. He also has considerable experience in the development of single-use disposable and absorbable polymer-based medical devices.

"Over the past year working with John has provided the SteriPro team an extra advantage in the world of sterilization science consulting. With his exceptional analytical and problem solving ability, allied to his experience with a range of sterilization technologies and medical device product development, we continue to bring exceptional knowledge and experience to our SteriPro Consulting services and Sterigenics' medical device and pharmaceutical customers. In addition, the intellectual property John brings to Sterigenics with his extensive development work with the VDmax methodology will give us an important competitive advantage. " said Lisa Foster, Vice President of Sterigenics SteriPro Services.

About Sterigenics International

Sterigenics International, Inc., is a portfolio company of Silverfleet Capital (formerly PPM Capital Limited) and PPM America Capital Partners who manage private equity investments on behalf of Prudential plc, one of the United Kingdom's leading institutional investors, together with other clients. Headquartered in the Chicago suburb of Oak Brook, IL, Sterigenics is the world leader in contract sterilization and ionization services for the medical device, food safety and high performance/ specialty materials industries. The company has more than 1,200 employees and operates 39 service centers in North America, Europe and Asia.

All Topics